We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A Russian drugmaker has asked the Kremlin for a compulsory license allowing it to manufacture a generic of Gilead Sciences’ antiviral drug remdesivir. Read More
Sanofi and Regeneron have prevailed in a European patent ruling that protects their co-marketed cholesterol-lowering drug Praluent (alirocumab). Read More
The FDA has released a list of 223 drugs and medical countermeasures (MCMs) that it considers vital to U.S. patients or critical in a public health emergency, fulfilling a requirement of an executive order issued by President Trump in August. Read More
A growing number of states say they don’t plan to automatically distribute FDA-approved COVID-19 vaccines to their residents. Nevada, Oregon and Washington announced last week that they plan to conduct independent verification before distributing any vaccines. Read More
The Centers for Medicare & Medicaid Services (CMS) issued two new regulations this week — one a sweeping rule requiring health plans to be transparent about what they pay for medical procedures and drugs, and another seeking to ensure that Medicare, Medicaid and private health plans absorb the cost of a COVID-19 vaccine when one is ready. Read More
A coalition of cystic fibrosis patients, family members and supporters appealed in an open letter to Vertex Pharmaceuticals to expand access to the company’s drugs to treat the disease. Read More
Members of the Sackler family did in fact pressure Purdue Pharma executives to grow its market share of OxyContin and other opioids, according to allegations made in a hefty package of internal documents released by the House Committee on Oversight and Reform. Read More
Sanofi and GlaxoSmithKline (GSK) have signed an agreement with Gavi, the Vaccine Alliance pledging to provide 200 million doses of their COVID-19 vaccine to the COVAX initiative should the vaccine clear regulatory hurdles. Read More